LOW vs MRSN · P/E 18, rev $49.03B vs rev $40.5M
Lowe's Companies Inc (LOW) versus Mersana Therapeutics Inc (MRSN) — a side-by-side from cached financials, not a winner call.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
Latest reported LOW revenue for 2026-07-31 was $49.03B. Net income was $4.03B. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
LOW currently screens at market cap $121.89B and trailing P/E 18.4. MRSN currently screens at market cap $145.4M.
Not investment advice. Open the LOW and MRSN stock pages for the full models.
Not investment advice.